Abstract
Neurocysticercosis is the commonest parasitic disease of the nervous system in humans, and constitutes a major public health problem for most of the developing world. The clinical manifestations of Neurocysticercosis (NCC) largely depend on number of lesions, site, and host immune response against the parasite. Diagnosis is mainly based upon neuro imaging studies and is supported by antibody/antigen detection in the serum and occasionally the cerebrospinal fluid. Randomized controlled trials evaluating the clinical benefit of treatment with cysticidal agents have shown hastened resolution of lesions in most, and reduced seizure recurrence in some studies. Outcome is favourable in single lesion parenchymal NCC but is guarded in multiple lesion and extra parenchymal NCC.
Similar content being viewed by others
References
Montano SM, Villaran MV, Ylquimiche L, Figueroa JJ, Rodriguez S, Bautista CT, et al; Cysticercosis Working Group in Peru. Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru. Neurology. 2005;65:229–33.
Medina MT, Aguilar-Estrada RL, Alvarez A, Duron RM, Martinez L, Dubon S, et al. Reduction in rate of epilepsy from neurocysticercosis by community interventions: the Salama, Honduras study. Epilepsia. 2011;52:1177–85.
Ndimubanzi PC, Carabin H, Budke CM, Nguyen H, Qian YJ, Rainwater E, et al. A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis. 2010;4:e870.
Prasad KN, Verma A, Srivastava S, Gupta RK, Pandey CM, Paliwal VK. An epidemiological study of asymptomatic neurocysticercosis in a pig farming community in northern India. Trans R Soc Trop Med Hyg. 2011;105:531–6.
Raina SK, Razdan S, Pandita KK, Sharma R, Gupta VP, Razdan S. Active epilepsy as indicator of neurocysticercosis in rural northwest India. Epilepsy Res Treat. 2012;2012:802747.
Singh G, Bawa J, Chinna D, Chaudhary A, Saggar K, Modi M, et al. Association between epilepsy and cysticercosis and toxocariasis: a population-based case–control study in a slum in India. Epilepsia. 2012;53:2203–8.
Singhi P, Singhi S. Neurocysticercosis in children. J Child Neurol. 2004;19:482–92.
Serpa JA, White Jr AC. Neurocysticercosis in the United States. Pathog Glob Health. 2012;106:256–60.
Del Brutto OH, Garcia HH. Neurocysticercosis. Handb Clin Neurol. 2013;114:313–25.
Estanol B, Corona T, Abad P. A prognostic classification of cerebral cysticercosis: therapeutic implications. J Neurol Neurosurg Psychiatry. 1986;49:1131–4.
Amaral L, Maschietto M, Maschietto R, Cury R, Ferreira NF, Mendonca R, et al. Ununsual manifestations of neurocysticercosis in MR imaging: analysis of 172 cases. Arq Neuro-psiquiatr. 2003;61:533–41.
Del Brutto OH. Neurocysticercosis in infants and toddlers: report of seven cases and review of published patients. Pediatr Neurol. 2013;48:432–5.
Singhi P, Ray M, Singhi S, Khandelwal N. Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy. J Child Neurol. 2000;15:207–13.
Singhi P. Neurocysticercosis. Ther Adv Neurol Disord. 2011;4:67–81.
Singhi P. Infectious causes of seizures and epilepsy in the developing world. Dev Med Child Neurol. 2011;53:600–9.
Talukdar B, Saxena A, Popli VK, Choudhury V. Neurocysticercosis in children: clinical characteristics and outcome. Ann Trop Paediatr. 2002;22:333–9.
Nash TE, Garcia HH. Diagnosis and treatment of neurocysticercosis. Nat Rev Neurol. 2011;7:584–94.
David S, Mathai E. Ocular cysticercosis–a review of 25 cases. J Assoc Physicians India. 2000;48:704–7.
Nash T. Edema surrounding calcified intracranial cysticerci: clinical manifestations, natural history, and treatment. Pathog Glob Health. 2012;106:275–9.
Lerner A, Shiroishi MS, Zee CS, Law M, Go JL. Imaging of neurocysticercosis. Neuroimaging Clin N Am. 2012;22:659–76.
de Souza A, Nalini A, Kovoor JM, Yeshraj G, Siddalingaiah HS, Thennarasu K. Perilesional gliosis around solitary cerebral parenchymal cysticerci and long-term seizure outcome: a prospective study using serial magnetization transfer imaging. Epilepsia. 2011;52:1918–27.
Ito A, Yamasaki H, Nakao M, Sako Y, Okamoto M, Sato MO, et al. Multiple genotypes of taenia solium–ramifications for diagnosis, treatment and control. Acta Trop. 2003;87:95–101.
Atluri SR, Singhi P, Khandelwal N, Malla N. Evaluation of excretory secretory and 10–30 kDa antigens of taenia solium cysticerci by EITB assay for the diagnosis of neurocysticercosis. Parasite Immunol. 2009;31:151–5.
Rodriguez S, Wilkins P, Dorny P. Immunological and molecular diagnosis of cysticercosis. Pathog Glob Health. 2012;106:286–98.
Atluri VS, Singhi PD, Khandelwal N, Malla N. 2D-PAGE analysis of taenia solium metacestode 10–30 kDa antigens for the serodiagnosis of neurocysticercosis in children. Acta Trop. 2011;118:165–9.
Del Brutto OH, Wadia NH, Dumas M, Cruz M, Tsang VC, Schantz PM. Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis. J Neurol Sci. 1996;142:1–6.
Del Brutto OH, Rajshekhar V, White Jr AC, Tsang VC, Nash TE, Takayanagui OM, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology. 2001;57:177–83.
Rajshekhar V, Haran RP, Prakash GS, Chandy MJ. Differentiating solitary small cysticercus granulomas and tuberculomas in patients with epilepsy. Clinical and computerized tomographic criteria. J Neurosurg. 1993;78:402–7.
Pretell EJ, Martinot C Jr, Garcia HH, Alvarado M, Bustos JA, Martinot C, et al; Cysticercosis Working Group in Peru. Differential diagnosis between cerebral tuberculosis and neurocysticercosis by magnetic resonance spectroscopy. J Comput Aassist Tomogr. 2005;29:112–4.
Singhi PD, Baranwal AK. Single small enhancing computed tomographic lesions in indian children–II. clinical features, pathology, radiology and management. J Trop Pediatr. 2001;47:266–70.
Singhi PD, Dinakaran J, Khandelwal N. Singhi SC one vs. two years of anti-epileptic therapy in children with single small enhancing CT lesions. J Trop Pediatr. 2003;49:274–8.
Sharma LN, Garg RK, Verma R, Singh MK, Malhotra HS. Seizure recurrence in patients with solitary cystic granuloma or single parenchymal cerebral calcification: a comparative evaluation. Seizure. 2013;22:840–5.
Abba K, Ramaratnam S, Ranganathan LN. Anthelmintics for people with neurocysticercosis. Cochrane Database Syst Rev. 2010;3:CD000215.
Otte WM, Singla M, Sander JW, Singh G. Drug therapy for solitary cysticercus granuloma: a systematic review and meta-analysis. Neurology. 2013;80:152–62.
Baird RA, Wiebe S, Zunt JR, Halperin JJ, Gronseth G, Roos KL. Evidence-based guideline: treatment of parenchymal neurocysticercosis: report of the guideline development subcommittee of the American academy of neurology. Neurology. 2013;80:1424–9.
Kaur S, Singhi P, Singhi S, Khandelwal N. Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis: a randomized, placebo-controlled double blind trial. Pediatr Infect Dis J. 2009;28:403–6.
Sinha S, Sharma BS. Intraventricular neurocysticercosis: a review of current status and management issues. Br J Neurosurg. 2012;26:305–9.
Khade P, Lemos RS, Toussaint LG. What is the utility of postoperative antihelminthic therapy after resection for intraventricular neurocysticercosis? World Neurosurg. 2013;79:558–67.
Sikasunge CS, Johansen MV, Phiri IK, Willingham AL 3rd, Leifsson PS. The immune response in Taenia solium neurocysticercosis in pigs is associated with astrogliosis, axonal degeneration and altered blood–brain barrier permeability. Vet Parasitol. 2009;160:242–50.
Conflict of Interest
None.
Source of Funding
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Singhi, P., Suthar, R. Neurocysticercosis. Indian J Pediatr 82, 166–171 (2015). https://doi.org/10.1007/s12098-014-1576-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-014-1576-3